Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology
Vishnu C. Damalanka, Zhenfu Han, Partha Karmakar, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 2, pp. 480-490
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis
Evette S. Radisky
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107347-107347
Open Access | Times Cited: 24
Cell surface–anchored serine proteases in cancer progression and metastasis
Carly Martin, Karin List
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 3, pp. 357-387
Open Access | Times Cited: 109
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
Jin Li, Fan Shen, Michael Weinfeld, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 98
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 43
Open Access | Times Cited: 97
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Edward R. Kastenhuber, Marisa Mercadante, Benjamin E. Nilsson-Payant, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 55
Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †
Michele Montaruli, Domenico Alberga, Fulvio Ciriaco, et al.
Molecules (2019) Vol. 24, Iss. 12, pp. 2233-2233
Open Access | Times Cited: 40
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
Lukas Wettstein, Philip Maximilian Knaff, Christian Kersten, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 17
Bioinformatics and computational analyses of kidney stone modulatory proteins lead to solid experimental evidence and therapeutic potential
Sunisa Yoodee, Visith Thongboonkerd
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114217-114217
Open Access | Times Cited: 10
Oncological aspects of urolithiasis
Jozef Marenčák
Urologie pro praxi (2025) Vol. 26, Iss. 1, pp. 17-22
Closed Access
Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature
Alexandre Murza, Sébastien P. Dion, Pierre‐Luc T. Boudreault, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 11, pp. 807-824
Open Access | Times Cited: 25
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin
Matthew Mahoney, Jonathan Helander, Anoopjit Singh Kooner, et al.
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 3
Mechanism-Based Macrocyclic Inhibitors of Serine Proteases
Vishnu C. Damalanka, Victoria S. Banas, Paolo De Bona, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4833-4854
Closed Access | Times Cited: 2
Synthetic and biological approaches to map substrate specificities of proteases
Shiyu Chen, Joshua J. Yim, Matthew Bogyo
Biological Chemistry (2019) Vol. 401, Iss. 1, pp. 165-182
Open Access | Times Cited: 18
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Edward R. Kastenhuber, Javier A. Jaimes, Jared L. Johnson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Hepsin regulates TGFβ signaling via fibronectin proteolysis
Denis Belitškin, Shishir M. Pant, Pauliina Munne, et al.
EMBO Reports (2021) Vol. 22, Iss. 11
Open Access | Times Cited: 14
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
Vincent Blay, Mu‐Chun Li, Sunita P. Ho, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 7, pp. 1309-1320
Open Access | Times Cited: 15
N-glycan in the scavenger receptor cysteine-rich domain of hepsin promotes intracellular trafficking and cell surface expression
Shijin Sun, Lina Wang, Shengnan Zhang, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 818-827
Closed Access | Times Cited: 13
Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression
Vishnu C. Damalanka, Jorine Voss, Matthew Mahoney, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 18158-18174
Open Access | Times Cited: 11
Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin
Vishnu C. Damalanka, Scott A. Wildman, James W. Janetka
MedChemComm (2019) Vol. 10, Iss. 9, pp. 1646-1655
Open Access | Times Cited: 12
ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
Xin Nie, Lingling Gao, Mingjun Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
M.C. Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Structure-Based Design of High-Affinity and Selective Peptidomimetic Hepsin Inhibitors
Philip Maximilian Knaff, Patrick Müller, Christian Kersten, et al.
Biomacromolecules (2022) Vol. 23, Iss. 6, pp. 2236-2242
Closed Access | Times Cited: 5
Design and synthesis of dye-conjugated hepsin inhibitors
Kyul Kim, Hongmok Kwon, Doyoung Choi, et al.
Bioorganic Chemistry (2019) Vol. 89, pp. 102990-102990
Closed Access | Times Cited: 6
Understanding the link between kidney stones and cancers of the upper urinary tract and bladder.
Meredith Mihalopoulos, Alan Yaghoubian, Shirin Razdan, et al.
PubMed (2022) Vol. 10, Iss. 5, pp. 277-298
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top